Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Oct:99:269-271.
doi: 10.1016/j.ijid.2020.08.002. Epub 2020 Aug 6.

Severe immune thrombocytopenia in a critically ill COVID-19 patient

Ziga Martincic  1 , Barbara Skopec  2 , Karla Rener  2 , Matej Mavric  3 , Tomaz Vovko  3 , Matjaz Jereb  4 , Milica Lukic  3
Affiliations
Case Reports

Severe immune thrombocytopenia in a critically ill COVID-19 patient

Ziga Martincic et al. Int J Infect Dis. 2020 Oct.

Abstract

The novel coronavirus SARS-CoV-2 can cause a severe and even fatal respiratory illness named COVID-19. Apart from respiratory failure, COVID-19 may be associated with various autoimmune complications. We present a case of a critically ill patient with COVID-19 who developed severe immune thrombocytopenia that was successfully treated with a concomitant use of corticosteroids and intravenous immunoglobulins.

Keywords: COVID-19; SARS-CoV-2; corticosteroids; immune thrombocytopenia; intravenous immunoglobulins.

PubMed Disclaimer

References

    1. Bomhof G., Mutsaers P.G.N.J., Leebeek F.W.G., te Boekhorst P.A.W., Hofland J., Croles F.N. COVID-19-associated immune thrombocytopenia. Br J Haematol Br J Haematol. 2020;190(2):e61–e64. - PMC - PubMed
    1. Brogly N., Devos P., Boussekey N., Georges H., Chiche A., Leroy O. Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia. J Infect. 2007;55(2):136–140. - PubMed
    1. Cines D.B., Bussel J.B., Liebman H.A., Luning Prak E.T. The ITP syndrome: Pathogenic and clinical diversity. Blood. 2009;113(26):6511–6521. - PMC - PubMed
    1. Galeotti C., Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 2020;(June):1–2. doi: 10.1038/s41584-020-0448-7. Online ahead of print. - DOI - PMC - PubMed
    1. Horby P., Lim W.S., Emberson J., Mafham M., Bell J., Linsell L. Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report. N Engl J Med. 2020;(July) doi: 10.1056/NEJMoa2021436. Online ahead of print. - DOI - PubMed

Publication types